Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Participants With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of ADL5859 in relieving pain
associated with rheumatoid arthritis (RA) compared with placebo and naproxen (similar to
Aleve®). A second objective is to see whether the effect of ADL5859 differs after a single
dose compared with multiple doses.